Article
- The EMBO Journal (2001) 20, 2214 - 2223
- doi:10.1093/emboj/20.9.2214
Patched1 interacts with cyclin B1 to regulate cell cycle progression
Elizabeth A. Barnes1, Monica Kong1, Vincent Ollendorff2 and Daniel J Donoghue1
- Department of Chemistry and Biochemistry, Center for Molecular Genetics, University of California, San Diego, La Jolla, CA 92093-0367, USA
- Present address: INSERM U119, 27 Bd Lei Roure, 13009 Marseille, France
Correspondence to:
Daniel J Donoghue, E-mail: ddonoghue@ucsd.edu
Received 10 January 2001; Accepted 6 March 2001; Revised 6 March 2001
Abstract
The initiation of mitosis requires the activation of M-phase promoting factor (MPF). MPF activation and its subcellular localization are dependent on the phosphorylation state of its components, cdc2 and cyclin B1. In a two-hybrid screen using a bait protein to mimic phosphorylated cyclin B1, we identified a novel interaction between cyclin B1 and patched1 (ptc1), a tumor suppressor associated with basal cell carcinoma (BCC). Ptc1 interacted specifically with constitutively phosphorylated cyclin B1 derivatives and was able to alter their normal subcellular localization. Furthermore, addition of the ptc1 ligand, sonic hedgehog (shh), disrupts this interaction and allows cyclin B1 to localize to the nucleus. Expression of ptc1 in 293T cells was inhibitory to cell proliferation; this inhibition could be relieved by coexpression of a cyclin B1 derivative that constitutively localizes to the nucleus and that could not interact with ptc1 due to phosphorylation-site mutations to Ala. In addition, we demonstrate that endogenous ptc1 and endogenous cyclin B1 interact in vivo. The findings reported here demonstrate that ptc1 participates in determining the subcellular localization of cyclin B1 and suggest a link between the tumor suppressor activity of ptc1 and the regulation of cell division. Thus, we propose that ptc1 participates in a G2/M checkpoint by regulating the localization of MPF.
Keywords:
- basal cell carcinoma,
- cytoplasmic retention signal,
- G2,
- M checkpoint,
- M-phase promoting factor,
- nevoid basal cell carcinoma syndrome



